CCPortal
DOI10.1073/pnas.2018627118
Modular complement assemblies for mitigating inflammatory conditions
Hainline K.M.; Shores L.S.; Votaw N.L.; Bernstein Z.J.; Kelly S.H.; Fries C.N.; Madhira M.S.; Gilroy C.A.; Chilkoti A.; Collier J.H.
发表日期2021
ISSN00278424
卷号118期号:15
英文摘要Complement protein C3dg, a key linkage between innate and adaptive immunity, is capable of stimulating both humoral and cell-mediated immune responses, leading to considerable interest in its use as a molecular adjuvant. However, the potential of C3dg as an adjuvant is limited without ways of controllably assembling multiple copies of it into vaccine platforms. Here, we report a strategy to assemble C3dg into supramolecular nanofibers with excellent compositional control, using β-tail fusion tags. These assemblies were investigated as therapeutic active immunotherapies, which may offer advantages over existing biologics, particularly toward chronic inflammatory diseases. Supramolecular assemblies based on the Q11 peptide system containing β-tail-tagged C3dg, B cell epitopes from TNF, and the universal T cell epitope PADRE raised strong antibody responses against both TNF and C3dg, and prophylactic immunization with these materials significantly improved protection in a lethal TNF-mediated inflammation model. Additionally, in a murine model of psoriasis induced by imiquimod, the C3dgadjuvanted nanofiber vaccine performed as well as anti-TNF monoclonal antibodies. Nanofibers containing only β-tail-C3dg and lacking the TNF B cell epitope also showed improvements in both models, suggesting that supramolecular C3dg, by itself, played an important therapeutic role. We observed that immunization with β-tail-C3dg caused the expansion of an autoreactive C3dg-specific T cell population, which may act to dampen the immune response, preventing excessive inflammation. These findings indicate that molecular assemblies displaying C3dg warrant further development as active immunotherapies. © 2021 National Academy of Sciences. All rights reserved.
英文关键词Active immunotherapy; Immune engineering; Immunoengineering; Self-assembly; Vaccine
语种英语
scopus关键词alanylcysteinyl glutaminylglutaminyllysylphenylalanylglutaminylphenylalanylglutaminylphenylalanylglutamylglutaminylglutaminyl amide; antipsoriasis agent; complement component C3; complement component C5a; epitope; interleukin 10; monoclonal antibody; nanofiber; tumor necrosis factor; unclassified drug; animal cell; animal tissue; antibody response; Article; B lymphocyte; B lymphocyte activation; CD4+ T lymphocyte; cell population; controlled study; enzyme linked immunosorbent assay; enzyme linked immunospot assay; female; helper cell; imiquimod-induced psoriasis; immune response; immunization; immunotherapy; in vitro study; in vivo study; inflammation; molecular cloning; mouse; nonhuman; priority journal; protein assembly; protein expression; protein purification; transmission electron microscopy
来源期刊Proceedings of the National Academy of Sciences of the United States of America
文献类型期刊论文
条目标识符http://gcip.llas.ac.cn/handle/2XKMVOVA/179884
作者单位Biomedical Engineering Department, Duke University, Durham, NC 27708, United States
推荐引用方式
GB/T 7714
Hainline K.M.,Shores L.S.,Votaw N.L.,et al. Modular complement assemblies for mitigating inflammatory conditions[J],2021,118(15).
APA Hainline K.M..,Shores L.S..,Votaw N.L..,Bernstein Z.J..,Kelly S.H..,...&Collier J.H..(2021).Modular complement assemblies for mitigating inflammatory conditions.Proceedings of the National Academy of Sciences of the United States of America,118(15).
MLA Hainline K.M.,et al."Modular complement assemblies for mitigating inflammatory conditions".Proceedings of the National Academy of Sciences of the United States of America 118.15(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hainline K.M.]的文章
[Shores L.S.]的文章
[Votaw N.L.]的文章
百度学术
百度学术中相似的文章
[Hainline K.M.]的文章
[Shores L.S.]的文章
[Votaw N.L.]的文章
必应学术
必应学术中相似的文章
[Hainline K.M.]的文章
[Shores L.S.]的文章
[Votaw N.L.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。